![Chris French](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris French
Direttore Tecnico/Scientifico/R&S presso CHECKMATE PHARMACEUTICALS, INC.
Profilo
Chris French is currently the Vice President-Scientific Affairs at Checkmate Pharmaceuticals, Inc. She holds a Master's in Business Administration from St. Thomas University (Florida) and an undergraduate degree from the University of Mankato.
Posizioni attive di Chris French
Società | Posizione | Inizio |
---|---|---|
CHECKMATE PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2016 |
Formazione di Chris French
University of Mankato | Undergraduate Degree |
St. Thomas University (Florida) | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Checkmate Pharmaceuticals, Inc.
![]() Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Chris French